Home » Topics » BioWorld Science

BioWorld Science
RSS

Biocad initiates phase I study of BCD-132 in patients with multiple sclerosis

June 25, 2018

iTeos Therapeutics completes series B financing to support immuno-oncology programs

June 25, 2018

Crinetics Pharmaceuticals awarded NIDDK grants

June 25, 2018

FDA accepts IND for lanifibranor in patients with type 2 diabetes and NAFLD

June 22, 2018

REACH1 study of ruxolitinib in steroid-refractory acute GvHD meets primary endpoint

June 22, 2018

Takeda acquires control of TiGenix

June 22, 2018

Synairgen reports interim data from phase II trial of SNG-001 in COPD

June 22, 2018

Phase II/III trial of NBTXR-3 in soft tissue sarcoma meets primary endpoint

June 22, 2018

FDA accepts sBLA for Opdivo plus low-dose Yervoy for first-line NSCLC

June 22, 2018

Revance initiates phase III program with RT-002 injectable for cervical dystonia

June 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...